Storys zum Thema Chemie

GEA Group Aktiengesellschaft

3

GEA supplies heat pumpos AS Utilitas in Tallinn

GEA Group Aktiengesellschaft

3

Key technology for bioprocesses

Helmholtz Munich

New Microscope Brings Glowing Cells into Focus

hubergroup Deutschland GmbH

3

Press Release - UV innovation across the board: hubergroup Print Solutions showcases strong portfolio at IST UV Days 2025

GEA Group Aktiengesellschaft

3

GEA : Supply of key components for water treatment solution at Lignatherm wood fiber insulation plant

Grünenthal Group

Maren Thurow starts as new Head Global Communications at Grünenthal

GEA Group Aktiengesellschaft

3

EEW and GEA launch strategic partnership for CO₂ capture

Aurubis AG

2

Press release: Leading global selenium producer RETORTE secures growth in future markets with new facility

nova-Institut GmbH

5

From Emissions to Solutions: CO₂-Based Graphite, Plastics, and Methanol win big at “Best CO₂ Utilisation 2025” Innovation Award

hubergroup Deutschland GmbH

6

Press Release - hubergroup Chemicals to showcase groundbreaking bio-based Oligomers for industrial UV-coatings at RadTech 2025

hubergroup Deutschland GmbH

2

Press Release - hubergroup takes BOPE films to a new level with the new Gecko 2-Component Varnish

GEA Group Aktiengesellschaft

2

Adaptability for reliable separation processes with GEA Varipond C

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

Isomorphic Labs

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...

hubergroup Deutschland GmbH

4

Press Release - hubergroup Chemicals Presents Groundbreaking Bio-Based UV Oligomers at the European Coatings Show 2025 at its Booth and in a Presentation

nova-Institut GmbH

3

“Best CO₂ Utilisation 2025”: Celebrating Pioneering Innovation in Carbon Capture and Utilisation Technologies

GEA Group Aktiengesellschaft

5

GEA Direct Sprayer DS 25: Less Water, Faster Cleaning

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA honors Theo Schlegelmilch for 40 years with the company

DHL Group

PM: Alexion und DHL Express setzen in Irland auf SAF für internationale Luftfrachtlieferung von Medikamenten / PR: Alexion and DHL Express Join Forces in Ireland’s First 100% Switch to SAF for International Air Delivery of Medicines

nova-Institut GmbH

6

CO₂ Revolution 2025: Fueling the Future, Capturing Possibilities

DHL Group

PM: DHL Group und Neste vertiefen Zusammenarbeit zur Senkung von Emissionen in der Logistik / PR: DHL Group and Neste to tighten collaboration to reduce logistics emissions

hubergroup Deutschland GmbH

8

Press Release - hubergroup unveils revolutionary DYNAMICA Ink Series

FCL Components Europe B.V.

FCL Components Officially Releases ATEX-Approved Relays

Norgine GmbH

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...